Volume : 09, Issue : 06, June – 2022
41.PRIMARY CARE PHYSICIANS’ UTILIZATION OF TYPE 2 DIABETES SCREENING GUIDELINES IN SAUDI ARABIA
Yara Shargi Alruwaili, Fahad Hamadan Alruwaili, Fahad Saleh Alruwaili, Ahmad Abdulkarim Alanizi, Ahmad Mohammed Aaleh
Study aim: This study aims to assess primary care physicians’ utilization of type 2 diabetes screening guidelines and referrals to behavioural interventions in Al-Jouf, KSA. Methods: This study adopted a retrospective longitudinal survey-based study design. In this study, the setting is primary health care setting in Al-Jouf, Saudi Arabia. We included primary healthcare physicians. A pre-designed questionnaire was used for data collection and data was managed and analysed using the Statistical Package for Social Sciences (SPSS) version 26. Results: The study included 395 physician whose age ranged from 25 to 58 years. Of all, 39% of physicians prefer using HbA1C and fasting blood glucose for screening pre-diabetes. The majority (80.3%) of physicians’ screening decisions are influenced by the screening guidelines. ADA (46.3%), and both USPSTF and ADA (46.6%) were the physicians’ most common preferences for diabetes screening. Nearly half of respondents (50.9%) use screening guidelines in 70-90% of their diabetes screening encounters. However, 39% and 37.7% reported utilizing USPSTF and ADA screening guidelines in 70-90% of their encounters, respectively. Conclusion: Our study shows that the majority of primary healthcare physicians are adherent to the diabetes screening guidelines in their practice. However, older doctors, males, those working in rural areas and those receiving highest and lowest number of visits per week require further awareness in order to increase their adherence to diabetes screening guidelines.
Cite This Article:
Please cite this article in press Yara Shargi Alruwaili et al, Primary Care Physicians’ Utilization Of Type 2 Diabetes Screening Guidelines In Saudi Arabia., Indo Am. J. P. Sci, 2022; 09(6).,
Number of Downloads : 10
1. Guariguata L, Whiting DR, Hambleton I, Beagley J , Linnenkamp U , Shaw JE. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical practice.2013 ;103(2014):137-149.
2. Eiman MI, Muna H, Abdelmoneim M. Lifestyle patterns and the awareness of the risks of non-communicable diseases in Sudan: a community study. Sudan Med J. 2014 August;50(2).
3. Elbagir M, Eltom MA, Elmahadi E, Berne C, Kadam I. A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in northern Sudan. Diabetes Care. 1996 Oct; 19(10):1126-1128.
4. Marshall, Sally M, Allan F. Clinical review-Prevention and early detection of vascular complications of diabetes. BMJ-International Edition 333.7566 (2006): 475-480.
5. Lee, H. B., et al. “Radical approach to diabetic nephropathy.” [internet]. Kidney International 72 (2007): S67-S70. [cited 2022 Jan 19]. Available from: http://www.nature.com/ki/journal/v72/n106s/full/5002389a.html
6. Charles A., et al. Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. Diabetes Care 23.9 (2000): 1339-1342.
7. International Diabetes Federation, clinical guidelines taskforce. Global guideline for type 2 diabetes [internet]. 2012 [cited 2022 Jan 20]. Available from: http://www.idf.org/sites/default/files/IDF-Guideline-for-Type-2-Diabetes.pdf
8. World Health Organization, ed. Oussama MN Guidelines for the prevention, management and care of diabetes mellitus [internet]. EMRO Technical Publications Series 2006; 32. [cited 2022 Jan 20]. Available from: http://applications.emro.who.int/dsaf/dsa664.pdf
9. International Diabetes Federation, ed. Alan S, Trisha D, Stephan C. IDF Global Guideline for Managing Older People with Type 2 Diabetes [internet]. 2013 [cited 2022 Jan 20]. Available from: https://www.idf.org/sites/default/files/IDF-Guideline-for-olderpeople-T2D.pdf
10. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: From pathophysiology to prevention and management. Lancet. 2011;378(9786):169-181. doi:10.1016/S0140-6736(11)60614-4.
11. American Diabetes Association. Standards of Medical Care in Diabetes — 2017. J Clin Appl Res Educ. 2017;40(January):Supplement 1.
12. Siu AL. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163(11):861-868. doi:10.7326/M15-2345.
13. Group LAR. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes. N Engl J Med. 2013;369(2):145-154. doi:10.1056/NEJMoa1212914.
14. Geiss LS, James C, Gregg EW, Albright A, Williamson DF, Cowie CC. Diabetes Risk Reduction Behaviors Among U.S. Adults with Prediabetes. Am J Prev Med. 2010;38(4):403-409. doi:10.1016/j.amepre.2009.12.029.
15. Sharma MD, Garber AJ. What is the best treatment for Prediabetes? Curr Diab Rep. 2009;9:335-341.
16. Prior M, Guerin M, Grimmer-Somers K. The effectiveness of clinical guideline implementation strategies – A synthesis of systematic review findings. J Eval Clin Pract. 2008;14(5):888-897. doi:10.1111/j.1365-2753.2008.01014.x.
17. Jain SH. Advancing the Science and Practice of Diabetes Prevention. Am J Prev Med. 2013;44(4):S297-S298. doi:10.1016/j.amepre.2013.02.001.
18. Mickan S, Burls A, Glasziou P. Patterns of ‘ leakage ’ in the utilisation of clinical guidelines : a systematic review. Postgrad Med J. 2011;87:670-679. doi:10.1136/pgmj.2010.116012.
19. Mainous AG, Tanner RJ, Scuderi CB, Porter M, Carek PJ. Prediabetes Screening and Treatment in Diabetes Prevention: The Impact of Physician Attitudes. J Am Board Fam Med. 2016;29(6):663-671. doi:10.3122/jabfm.2016.06.160138.
20. Tseng E, Greer RC, O’Rourke P, et al. Survey of primary care providers’ knowledge of screening for, diagnosing and managing prediabetes. J Gen Intern Med. 2017;32(11):1172-1178. doi:10.1007/s11606-017-4103-1.
21. Prevent Diabetes STAT | General Public [Internet]. Prev. Diabetes STAT. Available from: http://www.preventdiabetesstat.org
22. Final Recommendation Statement: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening – US Preventive Services Task Force [Internet]. Available from: http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/screening-for-abnormal-blood-glucose-and-type-2-diabetes
23. Health Plans Preventing Diabetes and Improving Well-Being [Internet]. AHIP. 2016 Available from: https://www.ahip.org/diabetes/
24. Gopalan A, Lorincz IS, Wirtalla C, Marcus SC, Long JA. Awareness of Prediabetes and Engagement in Diabetes Risk–Reducing Behaviors. Am J Prev Med. 2015;49:512–9.